cabozantinib,atezolizumab
roche
['contact03']
and here s the tweetorial of the p3 rct #contact03 just presented by #asco23 and now published in !!! first-ever rct to evaluate io response in the post-io setting, helping to inform decision making in dedicated clinical scenarios 
Incoming PGY-1 @BIDMC_IM | Postdoctoral GU Oncology Research Fellow @DanaFarber | MD, Class of 2020 @USJLiban | Interested in Oncology